Amgen Kineret Needs Enbrel Combo Study And Combo Use Warning - Cmte

Labeling for Amgen's rheumatoid arthritis product Kineret (anakinra) should carry a strong warning against use with TNF-inhibitors, pending a double-blind safety trial studying combination use with Immunex' Enbrel (etanercept), FDA's Arthritis Advisory Committee recommended Aug. 16.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet